Dec 13 (Reuters) - Vir Biotechnology said on Wednesday it will cut about 12% of its workforce, or about 75 positions, and reduce the number of sites it operates in, as part of its cost cut measures. (Reporting by Christy Santhosh; Editing by Shinjini Ganguli)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.23 USD | +7.86% | +3.52% | -18.19% |
Apr. 26 | Cytokinetics Appoints Sung Lee as CFO | MT |
Apr. 18 | Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.19% | 1.12B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology to cut about 75 jobs, shut some facilities